The Lancet The Lancet, Elsevier, 2019, 394 (10204), pp.1169-1180. ⟨10.1016/S0140-6736(19)31887-2⟩ The Lancet (London), 394, 1169-1180 Bhatt, D L, Steg, P G, Mehta, S R, Leiter, L A, Simon, T, Fox, K, Held, C, Andersson, M, Himmelmann, A, Ridderstråle, W, Chen, J, Song, Y, Diaz, R, Goto, S, James, S K, Ray, K K, Parkhomenko, A N, Kosiborod, M N, McGuire, D K, Harrington, R A & THEMIS Steering Committee and Investigators 2019, ' Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI) : a phase 3, placebo-controlled, randomised trial ', Lancet, vol. 394, no. 10204, pp. 1169-1180 . https://doi.org/10.1016/S0140-6736(19)31887-2 The Lancet (London), 394, 10204, pp. 1169-1180
Kefer, J, Tzikas, A, Freixa, X, Shakir, S, Gafoor, S, Nielsen-Kudsk, J E, Berti, S, Santoro, G, Aminian, A, Landmesser, U, Nietlispach, F, Ibrahim, R, Danna, P L, Benit, E, Budts, W, Stammen, F, De Potter, T, Tichelbäcker, T, Gloekler, S, Kanagaratnam, P, Costa, M, Cruz-Gonzalez, I, Sievert, H, Schillinger, W, Park, J-W, Meier, B & Omran, H 2016, ' Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation ', International Journal of Cardiology, vol. 207, pp. 335-40 . https://doi.org/10.1016/j.ijcard.2016.01.003